GermlineSFTPA1mutation in familial idiopathic interstitial pneumonia and lung cancer
Autor: | Serge Amselem, Alice De Ligniville, Dominique Valeyre, Nadia Nathan, Bruno Copin, Annick Clement, Nathalie Kuziner, Thierry Chinet, Valérie Nau, Florence Dastot-Le Moal, Raphael Borie, Clément Picard, Lamisse Mansour Hendili, Violaine Giraud, Hilario Nunes, Laurent Gouya, Aurore Coulomb, Louis-Jean Couderc, Bruno Crestani, Martine Reynaud Gaubert, Sylvie Tissier, Maud Simansour, Marie Legendre, Philippe Duquesnoy, Caroline Kannengiesser, Laurie Galeron |
---|---|
Přispěvatelé: | CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Physiopathologie des maladies génétiques d'expression pédiatrique, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Pneumologie et d'Oncologie Thoracique [AP-HP Hôpital Ambroise-Paré], Hôpital Ambroise Paré [AP-HP], Service de pneumologie [Hôpital Foch], Hôpital Foch [Suresnes], Hypoxie et Poumon : pneumopathologies fibrosantes, modulations ventilatoires et circulatoires (H&P), Université Paris 13 (UP13)-UFR SMBH, Service de pneumologie [Avicenne], Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Recherche Saint-Antoine (UMRS893), Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS), Hôpital Nord [CHU - APHM], Service de pneumologie et oncologie thoracique [CHU Ambroise Paré], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Centre Hospitalier Universitaire Ambroise Paré (CHU Ambroise Paré), Service de Pneumologie [Bichat], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Faculté de Médecine Xavier Bichat, Service de Pneumologie et Centre de Compétence des Maladies Pulmonaires Rares [AP-HP Hôpital Bichat, Paris], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Physiopathologie et Epidémiologie des Maladies Respiratoires (PHERE (UMR_S_1152 / U1152)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Pierre et Marie Curie - Paris 6 (UPMC), Centre de recherche biomédicale Bichat-Beaujon (CRB3), Service de Pneumologie pédiatrique [CHU Trousseau], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de Biochimie [Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Service de génétique et embryologie médicales [CHU Trousseau], Centre de référence national pour les maladies respiratoires rares de l’enfant RespiRare [CHU Trousseau], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Trousseau [APHP], Service de pathologie [CHU Trousseau], COMBE, Isabelle, Service de pneumologie, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), Service des maladies respiratoires, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Avicenne-Jean Verdier-René Muret, AP-HP, Service d'Hématologie Biologique, Hôpital Robert-Debré, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), Centre de recherche sur l'Inflammation (CRI (UMR_S_1149 / ERL_8252 / U1149)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Laboratory of Excellence GR-Ex ' The red cell : from genesis to death ', PRES Sorbonne Paris Cité |
Rok vydání: | 2016 |
Předmět: |
Male
0301 basic medicine Pathology Lung Neoplasms Disease ABCA3 medicine.disease_cause Idiopathic pulmonary fibrosis 0302 clinical medicine SFTPA2 [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases Missense mutation Genetics (clinical) 0303 health sciences Mutation Pulmonary Surfactant-Associated Protein A General Medicine Middle Aged respiratory system Pedigree 3. Good health medicine.anatomical_structure [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases Adenocarcinoma Female Adult medicine.medical_specialty Mutation Missense Biology 03 medical and health sciences Germline mutation Genetics medicine Humans Genetic Predisposition to Disease Idiopathic Interstitial Pneumonias Lung cancer Molecular Biology Idiopathic interstitial pneumonia Germ-Line Mutation Aged 030304 developmental biology Lung business.industry Cancer Sequence Analysis DNA medicine.disease respiratory tract diseases 030104 developmental biology Gene Expression Regulation 030228 respiratory system Immunology biology.protein business 030215 immunology |
Zdroj: | Human Molecular Genetics Human Molecular Genetics, 2016, 25 (8), pp.1457-1467. ⟨10.1093/hmg/ddw014⟩ Human Molecular Genetics, Oxford University Press (OUP), 2016, 25 (8), pp.1457-1467. ⟨10.1093/hmg/ddw014⟩ |
ISSN: | 1460-2083 0964-6906 |
Popis: | Background: Idiopathic interstitial pneumonia (IIP) comprise a heterogeneous group of rare lung parenchyma disorders with high morbidity and mortality. They have been associated with an increased frequency of lung cancer. A genetic cause is identified in up to 20% of familial cases, telomerase and surfactant genes (SFTPA2, SFTPB, SFTPC, ABCA3) mutations being the first etiologies. Objectives:This study investigates the implication of SFTPA1 (NM_005411) in 12 families affected by IPF and lung cancer. Methods:SFTPA1 was sequenced by Sanger method in 12 unrelated index cases. An informed signed consent was obtained for each patient. New SFTPA1 variations were studied with functional experimentations. Results: A heterozygous missense disease-causing mutation (p.Trp211Arg, W211R), in SFTPA1, that encodes the Surfactant Protein (SP)-A1, was identified in a large family. The affected members, aged 7 months to 59 years, presented with various forms of IIP, and adenocarcinoma. The W211R mutation segregated in a dominant pathway with the disease. The mutation involved an amino-acid that is located in the carbohydrate recognition domain (CRD) of SP-A1 and involved a residue invariant throughout evolution in SP-A1, but also in SP-A2 and in other CRD-containing proteins. The W211R mutation impaired SP-A1 secretion, and an abnormal expression pattern of SP-A was found in the alveolar epithelium of lung tissue from a patient carrying the SFTPA1 mutation. Conclusion: This first report of the involvement of SFTPA1 in a Mendelian disorder unveils the key role of SP-A1 in the pathophysiology of IIP from infancy to elderly, and open up a new field of research on the mechanisms involved in IIP and lung cancer. |
Databáze: | OpenAIRE |
Externí odkaz: |